{"id":459,"date":"2019-05-15T03:30:04","date_gmt":"2019-05-15T07:30:04","guid":{"rendered":"https:\/\/immunebiosolutions.com\/info\/?p=459"},"modified":"2023-03-28T15:27:44","modified_gmt":"2023-03-28T19:27:44","slug":"immune-bio-selected-for-the-pitch-competition-at-g20-yea","status":"publish","type":"post","link":"https:\/\/immunebiosolutions.com\/en\/immune-bio-selected-for-the-pitch-competition-at-g20-yea\/","title":{"rendered":"Immune Bio selected for the Pitch Competition at G20 YEA"},"content":{"rendered":"

Immune Biosolutions has been selected to present its Edible Antibodies technology in the G20 Young Entrepreneurs Alliance Event in Fukuoka, Japan (May 16-17, 2019).<\/p>\n

\n
\n
\n

The G20YEA presents the first edition of the “G20YEA CALL FOR IDEAS FOR SDGS”, an initiative created to reward the most innovative and effective business idea to achieve one or more UN Sustainable Development Goals. Fr\u00e9d\u00e9ric Leduc, CEO of Immune Biosolutions, is among a strong Canadian delegation of unique young entrepreneurs from all sectors, supported by Futurpreneur Canada.<\/p>\n

 <\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Immune Biosolutions has been selected to present its Edible Antibodies technology in the G20 Young Entrepreneurs Alliance Event in Fukuoka,…<\/p>\n","protected":false},"author":2,"featured_media":2694,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[15],"tags":[],"class_list":["post-459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"taxonomy_info":{"category":[{"value":15,"label":"News"}]},"featured_image_src_large":["https:\/\/immunebiosolutions.com\/wp-content\/uploads\/2019\/05\/g20-1024x949.jpeg",1024,949,true],"author_info":{"display_name":"jfares","author_link":"https:\/\/immunebiosolutions.com\/en\/author\/jfares\/"},"comment_info":0,"category_info":[{"term_id":15,"name":"News","slug":"news","term_group":0,"term_taxonomy_id":15,"taxonomy":"category","description":"","parent":0,"count":21,"filter":"raw","cat_ID":15,"category_count":21,"category_description":"","cat_name":"News","category_nicename":"news","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/posts\/459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/comments?post=459"}],"version-history":[{"count":1,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/posts\/459\/revisions"}],"predecessor-version":[{"id":2696,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/posts\/459\/revisions\/2696"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/media\/2694"}],"wp:attachment":[{"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/media?parent=459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/categories?post=459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/immunebiosolutions.com\/en\/wp-json\/wp\/v2\/tags?post=459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}